Yan Siyu, Liu Runqiu, Mao Manyun, Liu Zhaoqian, Zhang Wei, Zhang Yi, Li Jie, Peng Cong, Chen Xiang
Department of Dermatology, Xiangya Hospital of Central South University, Changsha, Hunan, China.
Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital of Central South University, Changsha, Hunan, China.
PeerJ. 2019 Aug 21;7:e7404. doi: 10.7717/peerj.7404. eCollection 2019.
Chronic spontaneous urticaria (CSU) is a common and recurrent autoimmune-related disease with unclear pathogenesis. Dysfunction of immune cells, such as T cells, mast cells, and basophils, is involved. Bacillus Calmette-Guerin polysaccharide nucleic acid (BCG-PSN), an immunomodulator partially extracted from BCG, can be used in the combined treatment of CSU with an unknown mechanism.
To study the therapeutic effect and mechanism of BCG-PSN on CSU, we initially assessed the clinical efficacy in 110 enrolled CSU patients of 4-week antihistamine monotherapy vs. antihistamine plus BCG-PSN combined therapy. Subsequently, to explore the further mechanism of BCG-PSN, the mast cell line RBL-2H3 pretreated with BCG-PSN was used to evaluate the transcriptional expression profiles via lncRNA sequencing. Real time PCR was conducted to validate the candidate gene expression.
We found no significant difference in treatment efficacy between the BCG-PSN group (71.7%) and the monotherapy group (71.9%). However, the average time of complete relief in the BCG-PSN group was significantly shorter than that in the monotherapy group (36.77 ± 17.33 vs. 51.27 ± 16.80, = 0.026). experiments showed that BCG-PSN inhibited β-hexosaminidase release rates in IgE-sensitized RBL-2H3 cells ( < 0.001). Sequencing data revealed the expression profiles of functional genes, including a significant decrease in Erb-B2 receptor tyrosine kinase 4, which can be regulated by the nuclear factor kappa B (NF-κB) pathway.
CSU is a chronic, recurrent disease with complex pathogenesis. Mast cells and basophils are the primary target cells of the disease. BCG-PSN decrease the β-HEX release rates and regulated IgE-mediated mast cell activation in RBL-2H3 cells by mediating immune-related gene expression including ERBB4. These findings suggest that BCG-PSN may mediate ERBB4 expression the NF-κB pathway and may have value in the treatment of CSU.
慢性自发性荨麻疹(CSU)是一种常见的复发性自身免疫相关疾病,其发病机制尚不清楚。免疫细胞功能异常,如T细胞、肥大细胞和嗜碱性粒细胞,均参与其中。卡介菌多糖核酸(BCG-PSN)是一种从卡介苗中部分提取的免疫调节剂,可用于CSU的联合治疗,但其机制尚不清楚。
为研究BCG-PSN对CSU的治疗效果和机制,我们首先评估了110例入选的CSU患者接受4周抗组胺单药治疗与抗组胺加BCG-PSN联合治疗的临床疗效。随后,为探索BCG-PSN的进一步机制,用BCG-PSN预处理的肥大细胞系RBL-2H3通过lncRNA测序评估转录表达谱。进行实时PCR以验证候选基因表达。
我们发现BCG-PSN组(71.7%)和单药治疗组(71.9%)的治疗效果无显著差异。然而,BCG-PSN组的完全缓解平均时间明显短于单药治疗组(36.77±17.33对51.27±16.80,P=0.026)。实验表明,BCG-PSN抑制IgE致敏的RBL-2H3细胞中β-己糖胺酶释放率(P<0.001)。测序数据揭示了功能基因的表达谱,包括Erb-B2受体酪氨酸激酶4显著降低,其可由核因子κB(NF-κB)途径调节。
CSU是一种发病机制复杂的慢性复发性疾病。肥大细胞和嗜碱性粒细胞是该疾病的主要靶细胞。BCG-PSN通过介导包括ERBB4在内的免疫相关基因表达,降低RBL-2H3细胞中β-HEX释放率并调节IgE介导的肥大细胞活化。这些发现表明,BCG-PSN可能通过NF-κB途径介导ERBB4表达,可能对CSU治疗有价值。